Stéphane Temmerman1, 7, Kevin Pethe2, 6, 7, Marcela Parra3, Sylvie Alonso2, 6, Carine Rouanet2, Thames Pickett3, Annie Drowart4, Anne-Sophie Debrie2, Giovanni Delogu3, 6, Franco D Menozzi2, Christian Sergheraert5, Michael J Brennan3, Françoise Mascart1
& Camille Locht21
Laboratory of Immunology, Erasme Hospital, Université Libre de Bruxelles, Route de Lennik, 808, B-1070 Brussels, Belgium.
2
Unité INSERM U629, IBL, Institut Pasteur de Lille, 1, Rue du Professor Calmette, F-59019 Lille Cedex, France.
3
Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland 20892, USA.
4
Department of Internal Medicine, Brugmann Hospital, Place Van Gehuchten, 4, B-1020 Brussels, Belgium.
5
CNRS-Université Lille 2 UMR8525, IBL, Institut Pasteur de Lille, 1, rue du Prof. Calmette, F-59019 Lille Cedex, France.
6
Present addresses: Department of Microbiology and Immunology, College of Veterinary Medicine, Cornell University, Ithaca, New York 14853, USA (K.P. and S.A.); Institute of Microbiology, Catholic University of the Sacred Heart, Rome, Italy (G.D.).
7
These authors contributed equally to this work.
Correspondence should be addressed to Camille Locht camille.locht@pasteur-lille.fr
